Documenting New Stability Data for Extension Requests
Pharmaceutical companies often seek shelf life extensions based on additional stability data generated post-approval. However, presenting this data to regulatory authorities like the EMA, USFDA, or CDSCO requires meticulous documentation, proper format, and compliance with ICH guidelines. This tutorial outlines how to collect, structure, and document new stability data effectively for extension requests. 📊 Step…
Read More “Documenting New Stability Data for Extension Requests” »